CD44 is a cell surface adhesion molecule demonstrated to be a receptor
for hyaluronate (HA). Since serum HA is known to increase in patients
with liver cirrhosis (LC), we investigated whether serum CD44 levels
are increased in patients with chronic liver diseases. Serum CD44 conc
entration in patients with LC was significantly (P < 0.05) higher than
that in patients with chronic hepatitis (CH). Patients with CH had al
so significantly more elevated levels of serum CD44 than normal contro
ls (P < 0.01). However, no significant difference was observed in seru
m CD44 levels among chronic persistent hepatitis, chronic aggressive h
epatitis with moderate activity (CAH 2A) and chronic aggressive hepati
tis with severe activity (CAH 2B). Similar results were obtained for s
erum HA. Serum CD44 levels also showed significant (P < 0.01) correlat
ion between serum HA in patients with CH and-LC. These results indicat
e that serum CD44 as well as HA is increased in patients with chronic
liver diseases, especially with LC.